NEW YORK April 26 - IBM and NetGenics said Thursday they have expanded their existing partnership to include an agreement for NetGenics to resell IBM's DiscoveryLink data integration software.

The companies began collaborating in 1999 on the development of DiscoveryLink.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.